Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 22 studies | 65% ± 17% | |
lung | 15 studies | 46% ± 21% | |
kidney | 7 studies | 42% ± 28% | |
bone marrow | 7 studies | 47% ± 22% | |
liver | 6 studies | 46% ± 27% | |
intestine | 5 studies | 53% ± 25% | |
brain | 5 studies | 42% ± 22% | |
lymph node | 5 studies | 53% ± 19% | |
heart | 4 studies | 19% ± 1% | |
uterus | 4 studies | 38% ± 14% | |
breast | 4 studies | 36% ± 14% | |
adipose | 3 studies | 38% ± 23% | |
adrenal gland | 3 studies | 51% ± 28% | |
placenta | 3 studies | 34% ± 12% | |
thymus | 3 studies | 32% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 18988.39 | 578 / 578 | 97% | 368.16 | 1116 / 1155 |
breast | 99% | 7585.45 | 455 / 459 | 93% | 186.42 | 1045 / 1118 |
thymus | 95% | 4337.34 | 620 / 653 | 95% | 161.10 | 576 / 605 |
kidney | 87% | 4508.16 | 77 / 89 | 90% | 289.80 | 810 / 901 |
uterus | 84% | 3150.76 | 143 / 170 | 83% | 158.08 | 383 / 459 |
prostate | 81% | 3294.64 | 198 / 245 | 86% | 106.32 | 432 / 502 |
bladder | 90% | 4634.86 | 19 / 21 | 76% | 195.47 | 382 / 504 |
intestine | 84% | 3605.22 | 809 / 966 | 79% | 160.31 | 417 / 527 |
esophagus | 58% | 2104.67 | 838 / 1445 | 90% | 175.84 | 165 / 183 |
adrenal gland | 71% | 2229.62 | 182 / 258 | 75% | 121.16 | 172 / 230 |
stomach | 61% | 2173.54 | 218 / 359 | 83% | 216.47 | 237 / 286 |
brain | 45% | 1948.26 | 1188 / 2642 | 96% | 252.58 | 680 / 705 |
ovary | 36% | 1144.06 | 65 / 180 | 89% | 172.39 | 382 / 430 |
skin | 35% | 1946.18 | 633 / 1809 | 85% | 222.51 | 403 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1007.66 | 29 / 29 |
peripheral blood | 100% | 89794.16 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 19369.01 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 11623.77 | 1201 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 7% | 171.67 | 22 / 328 | 93% | 290.54 | 165 / 178 |
blood vessel | 97% | 7116.66 | 1291 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 190.72 | 42 / 45 |
liver | 30% | 975.02 | 67 / 226 | 56% | 72.98 | 229 / 406 |
heart | 82% | 3443.38 | 702 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 39.07 | 34 / 80 |
muscle | 20% | 443.24 | 157 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140507 | Biological process | granzyme-mediated programmed cell death signaling pathway |
GO_0033371 | Biological process | T cell secretory granule organization |
GO_0033363 | Biological process | secretory granule organization |
GO_0016485 | Biological process | protein processing |
GO_0033364 | Biological process | mast cell secretory granule organization |
GO_0031214 | Biological process | biomineral tissue development |
GO_0030502 | Biological process | negative regulation of bone mineralization |
GO_0033382 | Biological process | maintenance of granzyme B location in T cell secretory granule |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0006915 | Biological process | apoptotic process |
GO_0033373 | Biological process | maintenance of protease location in mast cell secretory granule |
GO_0005615 | Cellular component | extracellular space |
GO_0044194 | Cellular component | cytolytic granule |
GO_0005576 | Cellular component | extracellular region |
GO_0042629 | Cellular component | mast cell granule |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0030141 | Cellular component | secretory granule |
GO_0005515 | Molecular function | protein binding |
Gene name | SRGN |
Protein name | Serglycin (Hematopoietic proteoglycan core protein) (Platelet proteoglycan core protein) (P.PG) (Secretory granule proteoglycan core protein) |
Synonyms | PRG PRG1 |
Description | FUNCTION: Plays a role in formation of mast cell secretory granules and mediates storage of various compounds in secretory vesicles. Required for storage of some proteases in both connective tissue and mucosal mast cells and for storage of granzyme B in T-lymphocytes. Plays a role in localizing neutrophil elastase in azurophil granules of neutrophils. Mediates processing of MMP2. Plays a role in cytotoxic cell granule-mediated apoptosis by forming a complex with granzyme B which is delivered to cells by perforin to induce apoptosis. Regulates the secretion of TNF-alpha and may also regulate protease secretion. Inhibits bone mineralization. . |
Accessions | ENST00000242465.4 P10124 |